Incyte (INCY) Overvalued, Thinks Goldman Sachs
Tweet Send to a Friend
Goldman Sachs maintained a Sell rating on Incyte (NASDAQ: INCY) and raised its price target of $26.00 (from $17.00). Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE